1 Min Read
* Promis Neurosciences provides third quarter update for 2017
* Promis Neurosciences Inc - PMN310 on track for 2019 initiation of clinical trials Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.